亚宝药业：与山西省中医院签订中药新药项目技术转让协议

Core Viewpoint - The company, Yabao Pharmaceutical, has signed a technology transfer agreement with Shanxi Traditional Chinese Medicine Research Institute for a new traditional Chinese medicine project, acquiring the clinical trial approval, patent rights, and related technical materials for the new drug "Chaiqin Ning Shen Granules" for 22 million yuan [1] Group 1 - The agreement was signed on August 4, indicating a strategic move by the company to expand its product portfolio in the traditional Chinese medicine sector [1] - The acquisition includes the clinical trial approval, which is crucial for the drug's development and commercialization [1] - The financial commitment of 22 million yuan reflects the company's investment in innovative drug development [1]